Compare · AVD vs NXTS
AVD vs NXTS
Side-by-side comparison of American Vanguard Corporation (AVD) and Nexentis Technologies Inc. (NXTS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AVD and NXTS operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- AVD is the larger of the two at $100.3M, about 28.0x NXTS ($3.6M).
- Over the past year, AVD is down 35.7% and NXTS is down 92.8% - AVD leads by 57.1 points.
- AVD has been more active in the news (19 items in the past 4 weeks vs 2 for NXTS).
- AVD has more recent analyst coverage (1 ratings vs 0 for NXTS).
- Company
- American Vanguard Corporation
- Nexentis Technologies Inc.
- Price
- $2.94-1.67%
- $5.38-15.01%
- Market cap
- $100.3M
- $3.6M
- 1M return
- +1.03%
- -4.95%
- 1Y return
- -35.67%
- -92.78%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 1998
- News (4w)
- 19
- 2
- Recent ratings
- 1
- 0
American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. It also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. The company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
Latest AVD
- Director Rosenbloom Keith M was granted 31,872 shares, increasing direct ownership by 93% to 66,283 units (SEC Form 4)
- SEC Form 4 filed by Officer Johnson David` T.
- SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Kaye Douglas
- SEC Form 8-K filed by American Vanguard Corporation
- CHIEF EXECUTIVE OFFICER Kaye Douglas bought $12,500 worth of shares (5,000 units at $2.50), increasing direct ownership by 2% to 300,251 units (SEC Form 4)
- American Vanguard Announces Voting Results Of 2026 Annual Meeting Of Stockholders
- Director Mcdougal Rubin J was granted 31,872 shares (SEC Form 4)
- SEC Form 3 filed by new insider Mcdougal Rubin J
- SEC Form 4 filed by Chief Commercial Officer Dipaola Michael Joseph
- Director Gottschalk Patrick E was granted 31,872 shares, increasing direct ownership by 17% to 223,577 units (SEC Form 4)
Latest NXTS
- Nexentis Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development
- SEC Form 10-Q filed by Nexentis Technologies Inc.
- Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone
- Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX's Algorithm Platform MITOLINE™
- Nexentis Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form EFFECT filed by Nexentis Technologies Inc.
- SEC Form S-3 filed by Nexentis Technologies Inc.
- Nexentis Technologies Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders
- SEC Form 10-K filed by Nexentis Technologies Inc.